sellWeak cluster of 410b5-1 plan
Iqbal J Hussain sold $97k of CNTA
General Counsel at Centessa Pharmaceuticals plc. 6,000 shares at an average of $16.18, traded Feb 18, 2025, filed Feb 19, 2025.
Warning score
5Value
$97k
6,000 shares
Holdings after
105,386
-5% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +10Trade size$97k at market
- 0Share of holdings soldSold 5.4% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001847903-25-000033, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 18, 2025 | MOption exercise Ordinary Shares10b5-1 | +6,000 | $5.84 | $35k | 111,386 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -4,612 | $15.91 | $73k | 106,774 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -1,388 | $17.05 | $24k | 105,386 | Feb 19, 2025 |
| Feb 18, 2025 | MOption exercise Share Option (right to buy)derivative10b5-1 | -6,000 | $0.00 | $0 | 315,559 | Feb 19, 2025 |
Related signals
Other insiders at Centessa Pharmaceuticals plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | Centessa Pharmaceuticals plc | Mario Alberto Accardi President, Orexin Program | $210k 15,000 shares | -6% | |
| 11Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $168k 12,000 shares | -10% | |
| 6Weak | Centessa Pharmaceuticals plc | Gregory M Weinhoff Chief Business Officer | $139k 10,000 shares | -8% | |
| 31Weak | Centessa Pharmaceuticals plc | Saurabh Saha Chief Executive Officer | $695k 55,000 shares | -20% | |
| 0Weak | Centessa Pharmaceuticals plc | Gregory M Weinhoff Chief Business Officer | $128k 10,000 shares | -8% | |
| 24Weak | Centessa Pharmaceuticals plc | Saurabh Saha Chief Executive Officer | $699k 55,000 shares | -20% | |
| 48Moderate | CNTAbuy Centessa Pharmaceuticals plc | Arjun Goyal director | $5.9M 462,585 shares | - | |
| 0Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $4,354 311 shares | -0% | |
| 4Weak | Centessa Pharmaceuticals plc | Iqbal J Hussain General Counsel | $80k 5,689 shares | -5% | |
| 21Weak | Centessa Pharmaceuticals plc | Gregory M Weinhoff Chief Business Officer | $160k 11,742 shares | -9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.